HAYWARD, Calif.--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules for patients with cancer and ...
We changed the address of the Stockhouse website from www.stockhouse.com to stockhouse.com. When this page refreshes you will be logged in with the new address ...
RALEIGH, NC (News Release) — The federal Centers for Medicare & Medicaid Services (CMS) today awarded North Carolina $213 million through the Rural Health Transformation Program (RHTP). These funds ...
55+ Programs are in person at 55+ Centers unless otherwise noted. A 55+ Pass is required to participate starting at a $20 annual fee. To join or register, go to registration.arlingtonva.us or call 703 ...
Hosted on MSN
Compass Pathways outlines FDA engagement and accelerated pathways for COMP360 in TRD while advancing PTSD program
Nath stated, "We plan to meet with the FDA to discuss these results and explore next steps in getting COMP360 to patients as rapidly as possible." Loxam reiterated, "We are finalizing a PTSD study and ...
Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. Membership (fee-based) Forbes Human Resources Council is an invitation-only, fee-based ...
Honor your pastor in our special Pastor Appreciation page that will publish on Saturday, October 11, 2025. This will include a photo and message for only $40. Once we receive this submission, we will ...
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback